-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Alpine Immune Sciences, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2017 to Q2 2022.
- Alpine Immune Sciences, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending June 30, 2022 was $100K.
- Alpine Immune Sciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $155K, a 237% increase from 2022.
- Alpine Immune Sciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $46K.
- Alpine Immune Sciences, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$214K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)